Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Blend Labs, Inc.
Report date June 07, 2024 · Filed June 12, 2024
Section 16 reporting ended · disclosed 2024-06-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,091,986 |
Reported balance
After 2024-06-07 transaction · row 1
1 source rowRow 1 · 2024-06-07 · Exercise / conversion · Acquired 27,760 · Balance 1,091,986 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 27,760 |
Reported balance
After 2024-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-06-07 · Grant · Acquired 27,760 · Balance 27,760 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. F2: The RSUs were fully vested as of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-06-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-06-07 · Exercise / conversion · Disposed 27,760 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. F2: The RSUs were fully vested as of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock.
F2: The RSUs were fully vested as of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2024 Filed Jun 12, 2024 00:31 UTC | Blend Labs, Inc. BLND · Entity 5752 | Exercise / conversionRestricted Stock Units · Derivative | 27,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016444 · form4-06122024_120659.xml · derivative · entry 3 Collard Erin James · CIK 0001868595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 27,760 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. F2 · derivative.exercise_date: The RSUs were fully vested as of the grant date. F2 · derivative.expiration_date: The RSUs were fully vested as of the grant date. Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 00:31 UTC | Blend Labs, Inc. BLND · Entity 5752 | GrantRestricted Stock Units · Derivative | 27,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016444 · form4-06122024_120659.xml · derivative · entry 2 Collard Erin James · CIK 0001868595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,760 Underlying: Class A Common Stock · 27,760 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. F2 · derivative.exercise_date: The RSUs were fully vested as of the grant date. F2 · derivative.expiration_date: The RSUs were fully vested as of the grant date. Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 00:31 UTC | Blend Labs, Inc. BLND · Entity 5752 | Exercise / conversionClass A Common Stock | 27,760 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-016444 · form4-06122024_120659.xml · nonDerivative · entry 1 Collard Erin James · CIK 0001868595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,091,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 21:48 UTC | Blend Labs, Inc. BLND · Entity 5752 | Exercise / conversionRestricted Stock Units · Derivative | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059594 · doc4.xml · derivative · entry 3 Collard Erin James · CIK 0001868595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 8,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. F2 · derivative.exercise_date: The RSUs were fully vested as of the grant date. F2 · derivative.expiration_date: The RSUs were fully vested as of the grant date. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 21:48 UTC | Blend Labs, Inc. BLND · Entity 5752 | GrantRestricted Stock Units · Derivative | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059594 · doc4.xml · derivative · entry 2 Collard Erin James · CIK 0001868595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,333 Underlying: Class A Common Stock · 8,333 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. F2 · derivative.exercise_date: The RSUs were fully vested as of the grant date. F2 · derivative.expiration_date: The RSUs were fully vested as of the grant date. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 21:48 UTC | Blend Labs, Inc. BLND · Entity 5752 | Exercise / conversionClass A Common Stock | 8,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-059594 · doc4.xml · nonDerivative · entry 1 Collard Erin James · CIK 0001868595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,064,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.